Thursday, 30 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > Higher buprenorphine dose safe for people with fentanyl addiction: study
Health and Wellness

Higher buprenorphine dose safe for people with fentanyl addiction: study

Last updated: September 26, 2024 2:27 am
Share
Higher buprenorphine dose safe for people with fentanyl addiction: study
SHARE

A recent study has found that patients who receive higher doses of buprenorphine, a medication commonly used to alleviate opioid withdrawal and cravings, are less likely to be hospitalized and less likely to discontinue treatment. This discovery contradicts current federal guidelines, which recommend a target dose of 16 mg. With fentanyl becoming more prevalent in the U.S. drug supply, addiction treatment providers have reported that patients often require significantly higher doses of buprenorphine to reduce or stop their illicit opioid use.

The study, published in JAMA Network Open, revealed that patients receiving 24 mg or more of buprenorphine were less likely to visit the emergency room or require other inpatient care compared to those receiving lower doses. Initially, the researchers set out to investigate whether higher doses of buprenorphine were associated with harmful outcomes but instead found a benefit. Patients receiving higher doses were not only less likely to end up in the emergency department but also took longer to require emergency care.

Buprenorphine, also known as Suboxone, and methadone are considered the gold standard for treating opioid use disorder. However, as the drug supply has become more potent, transitioning patients from fentanyl to addiction medications like buprenorphine has become more challenging. Buprenorphine can cause precipitated withdrawal if not administered correctly, leading to symptoms such as pain, anxiety, sweating, and gastrointestinal distress. Despite being an opioid itself, buprenorphine binds to the brain’s opioid receptors differently than pain medications or fentanyl, effectively outcompeting other opioid molecules for receptor space without providing the same euphoric or analgesic effects.

See also  You cannot tell a good story if you do not know how to listen

To address these challenges, addiction doctors have explored various methods for initiating patients on buprenorphine, including large loading doses, microdosing, and combining the medication with small amounts of ketamine. The new study adds to existing evidence supporting the safety and efficacy of higher buprenorphine doses in helping patients remain in treatment. Another recent study showed that higher initial buprenorphine doses are linked to lower mortality rates, prompting the American Society of Addiction Medicine to advocate for giving clinicians more flexibility in determining medically appropriate doses.

Despite the positive outcomes associated with higher buprenorphine doses, access to these doses remains limited. Stigma surrounding addiction medications, including buprenorphine, often deters doctors from prescribing them. Additionally, insurance requirements, prior authorization processes, and FDA recommendations can prevent doctors from prescribing doses exceeding 16 or 24 mg, leading to treatment failures for some patients.

Federal agencies are actively discussing the issue, with a recent “listening session” hosted by the Substance Abuse and Mental Health Services Administration, FDA, and National Institute on Drug Abuse to evaluate current buprenorphine dosing guidelines. The hope is that the growing body of evidence and evolving attitudes towards buprenorphine prescribing will prompt the FDA to reconsider its dosing recommendations, which could influence insurance coverage and state regulations.

In conclusion, the study’s findings underscore the importance of considering higher buprenorphine doses for patients with opioid use disorder. By recognizing the potential benefits of higher doses and addressing barriers to access, healthcare providers can better support individuals seeking treatment for opioid addiction.

TAGGED:AddictionbuprenorphinedosefentanylhigherpeopleSafeStudy
Share This Article
Twitter Email Copy Link Print
Previous Article Secret Service Botched Response to Trump Assassination Attempt: Report Secret Service Botched Response to Trump Assassination Attempt: Report
Next Article Carrie Ann Inaba Calls Anna Delvey’s DWTS Exit Interview ‘Dismissive’ Carrie Ann Inaba Calls Anna Delvey’s DWTS Exit Interview ‘Dismissive’
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Why Shares in Novo Nordisk Bumped Higher Today

Novo Nordisk is significantly enhancing its footprint in the U.S. manufacturing industry with plans for…

October 3, 2025

How to Watch 2025 Emmy Nominations Online

The 77th Emmy award season is upon us, and the excitement is building as the…

July 15, 2025

Biden Honors Navy SEAL Whose Innovations Transformed Battlefield Care

Dr. Frank Butler, a former Navy SEAL turned Navy doctor, was recently honored with the…

January 4, 2025

Significant Yuki Tsunoda future update issued by Red Bull boss Christian Horner as Isack Hadjar continues to impress

Yuki Tsunoda is currently facing mounting pressure and scrutiny as a result of his disappointing…

May 31, 2025

José María Velasco Lovingly Captured a Changing Mexico

The National Gallery in London is making strides to introduce British audiences to art beyond…

August 6, 2025

You Might Also Like

Alignment Healthcare Reports Second Profitable Quarter By Taming Costs
Health and Wellness

Alignment Healthcare Reports Second Profitable Quarter By Taming Costs

October 30, 2025
Blue Cross’ new algorithm for health care costs infuriates doctors
Health and Wellness

Blue Cross’ new algorithm for health care costs infuriates doctors

October 30, 2025
Eating patterns may be more closely tied to seasonal rhythms than previously thought
Health and Wellness

Eating patterns may be more closely tied to seasonal rhythms than previously thought

October 30, 2025
With A Doctor Shortage; Is Concierge Medicine Morally Acceptable?
Health and Wellness

With A Doctor Shortage; Is Concierge Medicine Morally Acceptable?

October 30, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?